Related references
Note: Only part of the references are listed.Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies
Denise Haslwanter et al.
CELL HOST & MICROBE (2022)
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Lindsey R. Baden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Advances in gene-based vaccine platforms to address the COVID-19 pandemic
Deborah Pushparajah et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Flavivirus vaccines: Virus-like particles and single-round infectious particles as promising alternatives
Esmeralda Cuevas-Juarez et al.
VACCINE (2021)
A Dengue Virus Serotype 1 mRNA-LNP Vaccine Elicits Protective Immune Responses
Clayton J. Wollner et al.
JOURNAL OF VIROLOGY (2021)
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in healthy adults: an observer-blind, randomised, phase 1 trial
Htay-Htay Han et al.
LANCET INFECTIOUS DISEASES (2021)
How NS1 Antibodies Prevent Severe Flavivirus Disease
Justin S. G. Ooi et al.
TRENDS IN BIOCHEMICAL SCIENCES (2021)
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
S. J. Thomas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A guide to vaccinology: from basic principles to new developments
Andrew J. Pollard et al.
NATURE REVIEWS IMMUNOLOGY (2021)
West Nile Virus: An Update on Pathobiology, Epidemiology, Diagnostics, Control and One Health Implications
Gervais Habarugira et al.
PATHOGENS (2020)
The epidemiology, clinical presentation, and predictors of severe Tick-borne encephalitis in Lithuania, a highly endemic country: A retrospective study of 1040 patients
Daiva Radzisauskiene et al.
PLOS ONE (2020)
Production and Biomedical Application of Flavivirus-like Particles
Ewelina Krol et al.
TRENDS IN BIOTECHNOLOGY (2019)
Protein Vaccination Directs the CD4+ T Cell Response toward Shared Protective Epitopes That Can Be Recalled after Influenza Virus Infection
Ajitanuj Rattan et al.
JOURNAL OF VIROLOGY (2019)
Enhanced immunogenicity and protective efficacy of a tetravalent dengue DNA vaccine using electroporation and intradermal delivery
Maya Williams et al.
VACCINE (2019)
Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection
Gustavo Cabral-Miranda et al.
VACCINES (2019)
Protective to a T: The Role of T Cells during Zika Virus Infection
Ryan D. Pardy et al.
CELLS (2019)
Rapid selection and identification of functional CD8+ T cell epitopes from large peptide-coding libraries
Govinda Sharma et al.
NATURE COMMUNICATIONS (2019)
A review of Dengvaxia?: development to deployment
Stephen J. Thomas et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy Model
Cindy Nuernberger et al.
JOURNAL OF VIROLOGY (2019)
Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naive adults
Susan B. Manoff et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Application of built-in adjuvants for epitope-based vaccines
Yao Lei et al.
PEERJ (2019)
Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization
Hsiao-Han Lin et al.
THERANOSTICS (2019)
Safety and Immunogenicity of a Tetravalent Dengue DNA Vaccine Administered with a Cationic Lipid-Based Adjuvant in a Phase 1 Clinical Trial
Janine R. Danko et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
Zika virus structural biology and progress in vaccine development
Hsiao-Han Lin et al.
BIOTECHNOLOGY ADVANCES (2018)
Biochemistry and Molecular Biology of Flaviviruses
Nicholas J. Barrows et al.
CHEMICAL REVIEWS (2018)
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials
Kayvon Modjarrad et al.
LANCET (2018)
Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe
Florian Douam et al.
TRENDS IN MICROBIOLOGY (2018)
A systematic approach to the development of a safe live attenuated Zika vaccine
Swee Sen Kwek et al.
NATURE COMMUNICATIONS (2018)
Evolving Epidemiology of Japanese Encephalitis: Implications for Vaccination
John P. Caldwell et al.
CURRENT INFECTIOUS DISEASE REPORTS (2018)
New Vaccine Technologies to Combat Outbreak Situations
Susanne Rauch et al.
FRONTIERS IN IMMUNOLOGY (2018)
DNA VaccinesHow Far From Clinical Use?
Dominika Hobernik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The immune response against flaviviruses
Jose Luis Slon Campos et al.
NATURE IMMUNOLOGY (2018)
Purified Inactivated Zika Vaccine Candidates Afford Protection against Lethal Challenge in Mice
Whitney R. Baldwin et al.
SCIENTIFIC REPORTS (2018)
The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design
Felix A. Rey et al.
EMBO REPORTS (2018)
Differentiation of germinal center B cells into plasma cells is initiated by high-affinity antigen and completed by Tfh cells
Nike J. Kraeutler et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study
Xavier Saez-Llorens et al.
LANCET INFECTIOUS DISEASES (2017)
Production of virus-like particles for vaccines
J. Fuenmayor et al.
NEW BIOTECHNOLOGY (2017)
Antibody-dependent enhancement of severe dengue disease in humans
Leah C. Katzelnick et al.
SCIENCE (2017)
Major findings and recent advances in virus like particle (VLP)-based vaccines
Mona O. Mohsen et al.
SEMINARS IN IMMUNOLOGY (2017)
Yellow fever live attenuated vaccine: A very successful live attenuated vaccine but still we have problems controlling the disease
Alan D. T. Barrett
VACCINE (2017)
Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age
Scott B. Halstead
VACCINE (2017)
Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity
John J. Suschak et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Live Attenuated Yellow Fever 17D Vaccine: A Legacy Vaccine Still Controlling Outbreaks In Modern Day
Natalie D. Collins et al.
CURRENT INFECTIOUS DISEASE REPORTS (2017)
Phase 1 Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults in the United States
Alexander C. Schmidt et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Recombinant and epitope-based vaccines on the road to the market and implications for vaccine design and production
Patricio Oyarzun et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Micro- and nanoparticulates for DNA vaccine delivery
Eric Farris et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2016)
New developments in flavivirus drug discovery
W. Mei Kok
EXPERT OPINION ON DRUG DISCOVERY (2016)
A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone
Jorge E. Osorio et al.
EXPERT REVIEW OF VACCINES (2016)
A Tetravalent Formulation Based on Recombinant Nucleocapsid-like Particles from Dengue Viruses Induces a Functional Immune Response in Mice and Monkeys
Lazaro Gil et al.
JOURNAL OF IMMUNOLOGY (2016)
Rapid development of a DNA vaccine for Zika virus
Kimberly A. Dowd et al.
SCIENCE (2016)
Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains
Richard C. Condit et al.
VACCINE (2016)
Vector-free transmission and persistence of Japanese encephalitis virus in pigs
Meret E. Ricklin et al.
NATURE COMMUNICATIONS (2016)
Yellow fever vaccine-associated viscerotropic disease: current perspectives
Roger E. Thomas
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
An Adjuvanted, Tetravalent Dengue Virus Purified Inactivated Vaccine Candidate Induces Long-Lasting and Protective Antibody Responses Against Dengue Challenge in Rhesus Macaques
Stefan Fernandez et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2015)
Immunogenicity and Efficacy of Flagellin-Envelope Fusion Dengue Vaccines in Mice and Monkeys
Ge Liu et al.
CLINICAL AND VACCINE IMMUNOLOGY (2015)
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
S. R. Hadinegoro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination
P. Robert Beatty et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Next generation dengue vaccines: A review of the preclinical development pipeline
Kirsten S. Vannice et al.
VACCINE (2015)
Clinical evaluation strategies for a live attenuated tetravalent dengue vaccine
Alexander Roberto Precioso et al.
VACCINE (2015)
Live attenuated vaccines: Historical successes and current challenges
Philip D. Minor
VIROLOGY (2015)
Raising Expectations For Subunit Vaccine
John T. Schiller et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases
Thomas Grunwald et al.
CLINICAL AND EXPERIMENTAL VACCINE RESEARCH (2015)
A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available
Tomohiro Ishikawa et al.
VACCINE (2014)
Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2
Dong Yang et al.
VACCINE (2014)
Dengue Antibody- Dependent Enhancement: Knowns and Unknowns
Scott B. Halstead
MICROBIOLOGY SPECTRUM (2014)
Modern Subunit Vaccines: Development, Components, and Research Opportunities
Peter Michael Moyle et al.
CHEMMEDCHEM (2013)
Live attenuated tularemia vaccines: Recent developments and future goals
Mark E. Marohn et al.
VACCINE (2013)
Flaviviruses: braking the entering
Theodore C. Pierson et al.
CURRENT OPINION IN VIROLOGY (2013)
Recombinant vaccines and the development of new vaccine strategies
I. P. Nascimento et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2012)
Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges
Iris Delrue et al.
EXPERT REVIEW OF VACCINES (2012)
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
Ruklanthi de Alwis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Viscerotropic disease: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
Mark D. Gershman et al.
VACCINE (2012)
A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial
Julie E. Ledgerwood et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
An Inactivated Cell-Culture Vaccine against Yellow Fever
Thomas P. Monath et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Key Concepts of Clinical Trials: A Narrative Review
Craig A. Umscheid et al.
POSTGRADUATE MEDICINE (2011)
Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses
Shanfeng Li et al.
VACCINE (2011)
Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI)
David N. Taylor et al.
VACCINE (2011)
Prevention of tick-borne encephalitis by FSME-IMMUN® vaccines: Review of a clinical development programme
Alexandra Loew-Baselli et al.
VACCINE (2011)
Vaxfectin: a versatile adjuvant for plasmid DNA- and protein-based vaccines
Sean M. Sullivan et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
IMOJEV®: a Yellow fever virus-based novel Japanese encephalitis vaccine
Mohan Babu Appaiahgari et al.
EXPERT REVIEW OF VACCINES (2010)
Rationalizing the development of live attenuated virus vaccines
Adam S. Lauring et al.
NATURE BIOTECHNOLOGY (2010)
Immunogenicity of an inactivated Japanese encephalitis vaccine (JE-VAX) in humans over 20 years at USAMRIID: Using PRNT50 as an endpoint for immunogenicity
Ronald B. Reisler et al.
VACCINE (2010)
Adverse event reports following Japanese encephalitis vaccination in the United States, 1999-2009
Nicole P. Lindsey et al.
VACCINE (2010)
Inactivated yellow fever 17D vaccine: Development and nonclinical safety, immunogenicity and protective activity
Thomas P. Monath et al.
VACCINE (2010)
Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults
John J. Treanor et al.
VACCINE (2010)
Pathogenesis of Flavivirus Infections: Using and Abusing the Host Cell
Maria-Dolores Fernandez-Garcia et al.
CELL HOST & MICROBE (2009)
Immunogenicity and Protective Efficacy of a Recombinant Subunit West Nile Virus Vaccine in Rhesus Monkeys
Michael M. Lieberman et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Dengue Virus Pathogenesis: an Integrated View
Byron E. E. Martina et al.
CLINICAL MICROBIOLOGY REVIEWS (2009)
Tick-borne encephalitis virus - a review of an emerging zoonosis
K. L. Mansfield et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Live Chimeric and Inactivated Japanese Encephalitis Virus Vaccines Differ in Their Cross-Protective Values against Murray Valley Encephalitis Virus
Mario Lobigs et al.
JOURNAL OF VIROLOGY (2009)
Virus attenuation by genome-scale changes in codon pair bias
J. Robert Coleman et al.
SCIENCE (2008)
Germinal-center organization and cellular dynamics
Christopher D. C. Allen et al.
IMMUNITY (2007)
A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity
William F. McDonald et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
A live, attenuated recombinant West Nile virus vaccine
TP Monath et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Ensuring the quality, potency and safety of vaccines during preclinical development
Jose A. Lebron et al.
EXPERT REVIEW OF VACCINES (2005)
ChimeriVax-West Nile virus live-attenuated vaccine: Preclinical evaluation of safety, immunogenicity, and efficacy
J Arroyo et al.
JOURNAL OF VIROLOGY (2004)
Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus
AG Pletnev et al.
VIROLOGY (2003)
MRBAYES: Bayesian inference of phylogenetic trees
JP Huelsenbeck et al.
BIOINFORMATICS (2001)
Share Paper
